Notice Pursuant to the National Cooperative Research and Production Act of 1993-The Customer Experience Hub, 78902-78903 [2024-22069]
Download as PDF
78902
Federal Register / Vol. 89, No. 187 / Thursday, September 26, 2024 / Notices
Register pursuant to section 6(b) of the
Act on June 28, 2024 (89 FR 54044).
Suzanne Morris,
Deputy Director Civil Enforcement
Operations, Antitrust Division.
BILLING CODE P
DEPARTMENT OF JUSTICE
Antitrust Division
khammond on DSKJM1Z7X2PROD with NOTICES
Notice Pursuant to the National
Cooperative Research and Production
Act of 1993—The Institute of Electrical
and Electronics Engineers, Inc.
Notice is hereby given that, on July 1,
2024, pursuant to section 6(a) of the
National Cooperative Research and
Production Act of 1993, 15 U.S.C. 4301
et seq. (‘‘the Act’’), The Institute of
Electrical and Electronics Engineers,
Inc. (‘‘IEEE’’) has filed written
notifications simultaneously with the
Attorney General and the Federal Trade
Commission disclosing additions or
changes to its standards development
activities. The notifications were filed
for the purpose of extending the Act’s
provisions limiting the recovery of
antitrust plaintiffs to actual damages
under specified circumstances.
Specifically, 46 new standards have
been initiated, and 19 existing standards
are being revised. More detail regarding
these changes can be found at: https://
standards.ieee.org/about/sasb/sba/
20may2024/, https://standards.ieee.org/
about/sasb/sba/06jun2024/. The
following pre-standards activities
associated with IEEE Industry
Connections Activities were launched
or renewed: https://standards.ieee.org/
about/bog/cag/approvals/june2024/.
On September 17, 2004, the IEEE filed
its original notification pursuant to
section 6(a) of the Act. The Department
of Justice published a notice in the
Federal Register pursuant to section
6(b) of the Act on November 3, 2004 (69
FR 64105).
The last notification was filed with
the Department on April 11, 2024. A
notice was published in the Federal
Register pursuant to section 6(b) of the
Act on June 21, 2024 (89 FR 52090).
[FR Doc. 2024–22058 Filed 9–25–24; 8:45 am]
BILLING CODE P
VerDate Sep<11>2014
17:11 Sep 25, 2024
Jkt 262001
Antitrust Division
Notice Pursuant to the National
Cooperative Research and Production
Act of 1993—Senior Healthcare
Innovation Consortium
[FR Doc. 2024–22056 Filed 9–25–24; 8:45 am]
Suzanne Morris,
Deputy Director Civil Enforcement
Operations, Antitrust Division.
DEPARTMENT OF JUSTICE
Notice is hereby given that, on July
10, 2024, pursuant to section 6(a) of the
National Cooperative Research and
Production Act of 1993, 15 U.S.C. 4301
et seq. (‘‘the Act’’), Senior Healthcare
Innovation Consortium (‘‘SHIC’’) has
filed written notifications
simultaneously with the Attorney
General and the Federal Trade
Commission disclosing changes in its
membership. The notifications were
filed for the purpose of extending the
Act’s provisions limiting the recovery of
antitrust plaintiffs to actual damages
under specified circumstances.
Specifically, Prudent Homecare,
Bismarck, ND, and UnaliWear, Austin,
TX, have been added as parties to this
venture.
No other changes have been made in
either the membership or planned
activity of the group research project.
Membership in this group research
project remains open, and SHIC intends
to file additional written notifications
disclosing all changes in membership.
On November 02, 2022, SHIC filed its
original notification pursuant to section
6(a) of the Act. The Department of
Justice published a notice in the Federal
Register pursuant to section 6(b) of the
Act on November 23, 2022 (87 FR
71677).
The last notification was filed with
the Department on April 4, 2024. A
notice was published in the Federal
Register pursuant to section 6(b) of the
Act on June 21, 2024 (89 FR 52094).
Suzanne Morris,
Deputy Director Civil Enforcement
Operations, Antitrust Division.
[FR Doc. 2024–22090 Filed 9–25–24; 8:45 am]
BILLING CODE P
DEPARTMENT OF JUSTICE
Antitrust Division
Notice Pursuant to the National
Cooperative Research and Production
Act of 1993—Blockchain Security
Standards Council, Inc.
Notice is hereby given that, on July 9,
2024, pursuant to section 6(a) of the
National Cooperative Research and
Production Act of 1993, 15 U.S.C. 4301
et seq. (‘‘the Act’’), Blockchain Security
Standards Council, Inc. (‘‘BSSC’’) has
filed written notifications
PO 00000
Frm 00062
Fmt 4703
Sfmt 4703
simultaneously with the Attorney
General and the Federal Trade
Commission disclosing (1) the identities
of the parties to the venture and (2) the
nature and objectives of the venture.
The notifications were filed for the
purpose of invoking the Act’s provisions
limiting the recovery of antitrust
plaintiffs to actual damages under
specified circumstances.
Pursuant to section 6(b) of the Act, the
identities of the parties to the venture
are: Bastion Platforms, Inc., Campbell,
CA; Halbourn, Inc., Miami, FL;
Payward, Inc., San Francisco, CA; and
Zeppelin Group Ltd., London, UNITED
KINGDOM. The general area of BSSC’s
planned activity is to elevate trust and
confidence in blockchain systems and
applications through the development
and promotion of security standards and
audit frameworks and to undertake such
other activities as may from time to time
be appropriate to further such purpose.
Suzanne Morris,
Deputy Director Civil Enforcement
Operations, Antitrust Division.
[FR Doc. 2024–22073 Filed 9–25–24; 8:45 am]
BILLING CODE P
DEPARTMENT OF JUSTICE
Antitrust Division
Notice Pursuant to the National
Cooperative Research and Production
Act of 1993—The Customer Experience
Hub
Notice is hereby given that, on July 3,
2024, pursuant to section 6(a) of the
National Cooperative Research and
Production Act of 1993, 15 U.S.C. 4301
et seq. (‘‘the Act’’), The Customer
Experience Hub (‘‘CX Hub’’) has filed
written notifications simultaneously
with the Attorney General and the
Federal Trade Commission disclosing
changes in its membership. The
notifications were filed for the purpose
of extending the Act’s provisions
limiting the recovery of antitrust
plaintiffs to actual damages under
specified circumstances. Specifically,
Advanced Functional Fabrics of
America, Inc., Cambridge, MA; Alacura
Medical Transport Management, Inc.,
Dallas, TX; Amazon Web Services, Inc.,
Seattle, WA; AMPEL LLC dba AMPEL
BioSolutions LLC, Charlottesville, VA;
Aptima, Inc., Woburn, MA; Avsana
Labs, Inc., Dallas, TX; Axiom Space,
Inc., Houston, TX; Be Well Texas, San
Antonio, TX; BetterAge, Sunnyside, NY;
Bexar County Hospital District dba
University Health System, San Antonio,
TX; BioCytics, Inc., Huntersville, NC;
Boyd Biomedical, Inc., Lee, MA;
E:\FR\FM\26SEN1.SGM
26SEN1
khammond on DSKJM1Z7X2PROD with NOTICES
Federal Register / Vol. 89, No. 187 / Thursday, September 26, 2024 / Notices
Carolina BioOncology Institute PLLC,
Huntersville, NC; Clinicals Global Pty
Ltd., Fortitude Valley, AUSTRALIA;
Cure Experience Service LLC, New
York, NY; DesignPlex Biomedical LLC,
Fort Worth, TX; Detroit Association of
Black Organizations, Inc. (DABO),
Detroit, MI; DiversiTrials, Florence, KY;
Dynocardia, Inc., Cambridge, MA; Echo
Investment Capital, Oklahoma City, OK;
Elarex, Inc., Burlington, CANADA;
Emagine Solutions Technology LLC,
Tucson, AZ; Essex Management LLC,
Rockville, MD; Esvyda!, Inc., Campbell,
CA; Eztia Corp., Diamond Bar, CA;
Focused Ultrasound Foundation,
Charlottesville, VA; Galen Data, Inc.,
Houston, TX; GE Healthcare Technology
& Innovation Center, Niskayuna, NY;
Gryphon Scientific LLC, Takoma Park,
MD; IA Collaborative Management
Services LLC, Chicago, IL;
Implementation Science Center for
Cancer Control Equity (ISCCCE), Boston,
MA; InnoTech Precision Medicine, Inc.,
Lowell, MA; Inter Astra Institute,
McLean, VA; Maternal Newborn Health
Innovations, PBC (MNHI), Parsippany,
NJ; Maximus, Inc., McLean, VA;
MediMergent LLC, Rockville, MD;
Metronomic, Inc., Chantilly, VA; MidAtlantic Permanente Medical Group,
P.C., Rockville, MD; MitoChem
Therapeutics, Inc., Charleston, SC;
Namida Lab, Inc., Fayetteville, AR;
National Health Council, Inc.,
Washington, DC; NKILT Therapeutics,
Inc., Springfield, NJ; Northeastern
University, Boston, MA; OnKai, Inc.,
Boca Raton, FL; Parallax Advanced
Research Corp., Beavercreek, OH;
Pediatric Moonshot, Marina del Rey,
CA; Proov, Erie, CO; Quorum
Innovations LLC, Sarasota, FL; SANO
Healthcare Consultants LLC, Ontario,
CA; SEQSTER PDM, Inc., San Diego,
CA; Spring Discovery, Inc., San Carlos,
CA; Starling Medical, Inc., Houston, TX;
SubjectWell, Inc., Austin, TX;
Synthesize Consulting Group,
Woodbridge, CANADA; Texas A&M
University-Corpus Christi, Corpus
Christi, TX; The Emmes Company LLC,
Rockville, MD; The Termeer
Foundation, Boston, MA; The
University of Texas Health Science
Center at Tyler, Tyler, TX; Touch4Life,
Clarksville, MD; Triple Ring
Technologies, Inc., Newark, CA;
University of Connecticut Health
Center, Farmington, CT; University of
Illinois, Chicago, IL; University of
Illinois Urbana-Champaign, Urbana, IL;
University of Missouri System,
Columbia, MO; University of Texas
Health Science Center at Houston,
Houston, TX; University of Texas
Medical Branch at Galveston, Galveston,
VerDate Sep<11>2014
17:11 Sep 25, 2024
Jkt 262001
TX; University of Texas Southwestern
Medical Center, Dallas, TX; Washington
Global Health Alliance, Redmond, WA;
Washington University in St. Louis, St.
Louis, MO; and Wiliam Marsh Rice
University, Houston, TX, have been
added as parties to this venture.
No other changes have been made in
either the membership or planned
activity of the group research project.
Membership in this group research
project remains open, and CX Hub
intends to file additional written
notifications disclosing all changes in
membership.
On January 11, 2024, CX Hub filed its
original notification pursuant to section
6(a) of the Act. The Department of
Justice published a notice in the Federal
Register pursuant to section 6(b) of the
Act on April 16, 2024 (89 FR 26929).
The last notification was filed with
the Department on April 17, 2024. A
notice was published in the Federal
Register pursuant to section 6(b) of the
Act on June 21, 2024 (89 FR 52093).
78903
Clara, CA, have been added as parties to
this venture.
No other changes have been made in
either the membership or planned
activity of the group research project.
Membership in this group research
project remains open, and AIM
Photonics intends to file additional
written notifications disclosing all
changes in membership.
On June 16, 2016, AIM Photonics
filed its original notification pursuant to
section 6(a) of the Act. The Department
of Justice published a notice in the
Federal Register pursuant to section
6(b) of the Act on July 25, 2016 (81 FR
48450).
The last notification was filed with
the Department on March 28, 2024. A
notice was published in the Federal
Register pursuant to section 6(b) of the
Act on June 28, 2024 (89 FR 54044).
Suzanne Morris,
Deputy Director Civil Enforcement
Operations, Antitrust Division.
[FR Doc. 2024–22057 Filed 9–25–24; 8:45 am]
BILLING CODE P
Suzanne Morris,
Deputy Director Civil Enforcement
Operations, Antitrust Division.
DEPARTMENT OF JUSTICE
[FR Doc. 2024–22069 Filed 9–25–24; 8:45 am]
Antitrust Division
BILLING CODE P
Notice Pursuant to the National
Cooperative Research and Production
Act of 1993—Countering Weapons of
Mass Destruction
DEPARTMENT OF JUSTICE
Antitrust Division
Notice Pursuant to the National
Cooperative Research and Production
Act of 1993—Integrated Photonics
Institute for Manufacturing Innovation
Operating Under the Name of the
American Institute for Manufacturing
Integrated Photonics
Notice is hereby given that, on July 1,
2024, pursuant to section 6(a) of the
National Cooperative Research and
Production Act of 1993, 15 U.S.C. 4301
et seq. (‘‘the Act’’), The Integrated
Photonics Institute for Manufacturing
Innovation, operating under the name of
the American Institute for
Manufacturing Integrated Photonics
(‘‘AIM Photonics’’), has filed written
notifications simultaneously with the
Attorney General and the Federal Trade
Commission disclosing changes in its
membership. The notifications were
filed for the purpose of extending the
Act’s provisions limiting the recovery of
antitrust plaintiffs to actual damages
under specified circumstances.
Specifically, Kyocera International, Inc.,
San Diego, CA; AdvR, Inc., Bozeman,
MT; The Board of Trustees of The
University of Illinois, Urbana, IL; and
DeepSight Technology, Inc., Santa
PO 00000
Frm 00063
Fmt 4703
Sfmt 4703
Notice is hereby given that, on July 1,
2024, pursuant to section 6(a) of the
National Cooperative Research and
Production Act of 1993, 15 U.S.C. 4301
et seq. (‘‘the Act’’), Countering Weapons
of Mass Destruction (‘‘CWMD’’) has
filed written notifications
simultaneously with the Attorney
General and the Federal Trade
Commission disclosing changes in its
membership. The notifications were
filed for the purpose of extending the
Act’s provisions limiting the recovery of
antitrust plaintiffs to actual damages
under specified circumstances.
Specifically, 10x National Security LLC,
Leesburg, VA; BCG Federal Corp,
Washington, DC; Luxfer Magtech, Inc.,
Cincinnati, OH; Materic LLC, Baltimore,
MD; SPOC Proteomics Inc, Scottsdale,
AZ; Venti LLC, New Bern, NC; and
World Wide Technology LLC, St. Louis,
MO, have been added as parties to this
venture.
Also, Quicksilver Analytics, Inc.,
Hampstead, NC, has withdrawn as a
party to this venture.
No other changes have been made in
either the membership or planned
activity of the group research project.
Membership in this group research
E:\FR\FM\26SEN1.SGM
26SEN1
Agencies
[Federal Register Volume 89, Number 187 (Thursday, September 26, 2024)]
[Notices]
[Pages 78902-78903]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2024-22069]
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Antitrust Division
Notice Pursuant to the National Cooperative Research and
Production Act of 1993--The Customer Experience Hub
Notice is hereby given that, on July 3, 2024, pursuant to section
6(a) of the National Cooperative Research and Production Act of 1993,
15 U.S.C. 4301 et seq. (``the Act''), The Customer Experience Hub (``CX
Hub'') has filed written notifications simultaneously with the Attorney
General and the Federal Trade Commission disclosing changes in its
membership. The notifications were filed for the purpose of extending
the Act's provisions limiting the recovery of antitrust plaintiffs to
actual damages under specified circumstances. Specifically, Advanced
Functional Fabrics of America, Inc., Cambridge, MA; Alacura Medical
Transport Management, Inc., Dallas, TX; Amazon Web Services, Inc.,
Seattle, WA; AMPEL LLC dba AMPEL BioSolutions LLC, Charlottesville, VA;
Aptima, Inc., Woburn, MA; Avsana Labs, Inc., Dallas, TX; Axiom Space,
Inc., Houston, TX; Be Well Texas, San Antonio, TX; BetterAge,
Sunnyside, NY; Bexar County Hospital District dba University Health
System, San Antonio, TX; BioCytics, Inc., Huntersville, NC; Boyd
Biomedical, Inc., Lee, MA;
[[Page 78903]]
Carolina BioOncology Institute PLLC, Huntersville, NC; Clinicals Global
Pty Ltd., Fortitude Valley, AUSTRALIA; Cure Experience Service LLC, New
York, NY; DesignPlex Biomedical LLC, Fort Worth, TX; Detroit
Association of Black Organizations, Inc. (DABO), Detroit, MI;
DiversiTrials, Florence, KY; Dynocardia, Inc., Cambridge, MA; Echo
Investment Capital, Oklahoma City, OK; Elarex, Inc., Burlington,
CANADA; Emagine Solutions Technology LLC, Tucson, AZ; Essex Management
LLC, Rockville, MD; Esvyda!, Inc., Campbell, CA; Eztia Corp., Diamond
Bar, CA; Focused Ultrasound Foundation, Charlottesville, VA; Galen
Data, Inc., Houston, TX; GE Healthcare Technology & Innovation Center,
Niskayuna, NY; Gryphon Scientific LLC, Takoma Park, MD; IA
Collaborative Management Services LLC, Chicago, IL; Implementation
Science Center for Cancer Control Equity (ISCCCE), Boston, MA; InnoTech
Precision Medicine, Inc., Lowell, MA; Inter Astra Institute, McLean,
VA; Maternal Newborn Health Innovations, PBC (MNHI), Parsippany, NJ;
Maximus, Inc., McLean, VA; MediMergent LLC, Rockville, MD; Metronomic,
Inc., Chantilly, VA; Mid-Atlantic Permanente Medical Group, P.C.,
Rockville, MD; MitoChem Therapeutics, Inc., Charleston, SC; Namida Lab,
Inc., Fayetteville, AR; National Health Council, Inc., Washington, DC;
NKILT Therapeutics, Inc., Springfield, NJ; Northeastern University,
Boston, MA; OnKai, Inc., Boca Raton, FL; Parallax Advanced Research
Corp., Beavercreek, OH; Pediatric Moonshot, Marina del Rey, CA; Proov,
Erie, CO; Quorum Innovations LLC, Sarasota, FL; SANO Healthcare
Consultants LLC, Ontario, CA; SEQSTER PDM, Inc., San Diego, CA; Spring
Discovery, Inc., San Carlos, CA; Starling Medical, Inc., Houston, TX;
SubjectWell, Inc., Austin, TX; Synthesize Consulting Group, Woodbridge,
CANADA; Texas A&M University-Corpus Christi, Corpus Christi, TX; The
Emmes Company LLC, Rockville, MD; The Termeer Foundation, Boston, MA;
The University of Texas Health Science Center at Tyler, Tyler, TX;
Touch4Life, Clarksville, MD; Triple Ring Technologies, Inc., Newark,
CA; University of Connecticut Health Center, Farmington, CT; University
of Illinois, Chicago, IL; University of Illinois Urbana-Champaign,
Urbana, IL; University of Missouri System, Columbia, MO; University of
Texas Health Science Center at Houston, Houston, TX; University of
Texas Medical Branch at Galveston, Galveston, TX; University of Texas
Southwestern Medical Center, Dallas, TX; Washington Global Health
Alliance, Redmond, WA; Washington University in St. Louis, St. Louis,
MO; and Wiliam Marsh Rice University, Houston, TX, have been added as
parties to this venture.
No other changes have been made in either the membership or planned
activity of the group research project. Membership in this group
research project remains open, and CX Hub intends to file additional
written notifications disclosing all changes in membership.
On January 11, 2024, CX Hub filed its original notification
pursuant to section 6(a) of the Act. The Department of Justice
published a notice in the Federal Register pursuant to section 6(b) of
the Act on April 16, 2024 (89 FR 26929).
The last notification was filed with the Department on April 17,
2024. A notice was published in the Federal Register pursuant to
section 6(b) of the Act on June 21, 2024 (89 FR 52093).
Suzanne Morris,
Deputy Director Civil Enforcement Operations, Antitrust Division.
[FR Doc. 2024-22069 Filed 9-25-24; 8:45 am]
BILLING CODE P